Skip to content

Cognitive Behavioral Therapy combined Shugananshen granule in the treatment of insomnia

Cognitive Behavioral Therapy combined Shugananshen granule in the treatment of insomnia: A Clinical Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004627
Enrollment
Unknown
Registered
2021-03-24
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meet the relevant diagnostic criteria for sleep disorders in ICD-10; (2) PSQI scale test score >= 6 points; (3) Between 18 and 60 years old; (4) Sign the informed consent form; (5) Stable vital signs; (6) Conscious, able to cooperate to complete cognitive behavioral therapy.

Exclusion criteria

Exclusion criteria: (1) Secondary insomnia ; (2) Hamilton Anxiety Scale (HAMA) total score >= 14 points; (3) Hamilton Depression Scale (HAMD, 17 items) total score >= 18 points; (4) Those taking psychoactive drugs (anti-depressants, anti-anxiety drugs, etc.) at the same time; (5) Those who have taken sleeping medicines and supplements (melatonin, etc.) regularly within 2 weeks before treatment or during the same period; (6) Those who have serious diseases such as cardiovascular, lung, liver, kidney, or hematopoietic system, endocrine system, mental illness, brain organic disease, drug abuse, or obvious visual or hearing impairment; (7) Laboratory examinations and ECG examinations have obvious clinically significant abnormalities, and according to the investigator's judgment, the abnormalities may affect the drug evaluation or the safety of the subjects; (8) Pregnant or lactating women; (9) Alcoholism or drug dependence; (10) Those who are allergic to the experimental drugs or ingredients contained in this protocol; (11) Those who cannot complete the experiment or the researcher thinks they cannot be selected for other reasons. (12) Those who participated in other clinical trials within the past 3 months.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index Questionnaire;

Secondary

MeasureTime frame
Actigraphy;Traditional Chinese Medicine Syndrome Scale;Dysfunctional Beliefs and Attitudes about Sleep;Insomnia Severity Index;

Countries

China

Contacts

Public ContactWen-Jing Zhang

Shanghai Municipal Hospital of Traditional Chinese Medicine

carrie1072@sina.com+86 18616360246

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026